Funding for this research was provided by:
Helse Vest (911903, 911988)
Norges Forskningsråd (ES633272)
Bergens Forskningsstiftelse (BFS2017REK05)
Received: 3 January 2020
Accepted: 13 March 2020
First Online: 16 April 2020
Ethics approval and consent to participate
: Samples were collected following local regulations and the study was performed in the frame of a study (“Molecular neuropathologic investigation of neurodegenerative diseases”) approved by the Ethical Committee of the Medical University of Vienna (Nr. 396/2011). All experiments were performed in accordance with relevant Austrian guidelines and regulations. In addition, the work presented here was approved by the Regional Committee for Medical and Health Research Ethics, Western Norway (REK 2018/1666). The manuscript does not contain information or images that could lead to an identification of the individual or which could violate any personal rights.
: Not applicable.
: The authors declare that they have no competing financial interests.